Journal
ARCHIVES OF MEDICAL RESEARCH
Volume 45, Issue 8, Pages 730-737Publisher
ELSEVIER SCIENCE INC
DOI: 10.1016/j.arcmed.2014.11.008
Keywords
Blood-brain barrier; BBB; Endothelial cells; Proteomics; Neurodegenerative disease
Categories
Funding
- Ministere de l'Education Nationale, de de l'Enseignement Superieur et la Recherche
Ask authors/readers for more resources
The blood brain barrier (BBB) regulates the passage of endogenous and exogenous compounds and thus contributes to the brain homeostasis with the help of well-known proteins such as tight junction proteins, plasma membrane transporters and metabolic barrier proteins. In the last decade, proteomics have emerged as supplementary tools for BBB research. The development of proteomic technologies has provided several means to extend knowledge on the BBB and to investigate additional routes for the bypass of this barrier. Proteomics approaches have been used in vivo and also using in vitro BBB models to decipher the physiological characteristics and, under stress conditions, to understand the molecular mechanisms of brain diseases. This work has demonstrated that both quantitative global and targeted proteomics approaches are powerful and provide significant information on the brain microvessel endothelium. However, current knowledge is only partial and it is necessary to increase the studies using proteomics tools that will provide additional information concerning brain pathologies or BBB metabolism. Highly sensitive, accurate and specific protein quantification by quantitative targeted proteomics appears as an essential methodology for human BBB studies. (C) 2014 IMSS. Published by Elsevier Inc.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available